Research
Metabolic adaptation
A 1 mmol/l increase in fasting plasma glucose (FPG) is associated with a 17% increase in the risk of future cardiovascular events or death.
Practitioners should monitor fasting plasma glucose levels as a potential risk factor for cardiovascular events and mortality.
StrongSupportsmedium confidence
Among all subjects, a 1 mmol/l increase in fasting plasma glucose (FPG) or a 2.52 mmol/l increase in the 2-h post-OGTT glucose was associated with a hazard ratio increase in the risk of CV events or death of 1.17 (95% CI 1.13-1.22).
Why this rating
Based on a large prospective cohort study design.
Source
Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study
Anand Ss et al. · European Journal of Preventive Cardiology · 2011
cohort · n=18990Cited 108×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →